Identification | Back Directory | [Name]
(7S,9S)-9-(1,2-dihydroxyethyl)-6,7,9,11-tetrahydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione | [CAS]
210837-88-0 | [Synonyms]
13-dihydroadriamycinone (8S,10S)-8-(1,2-Dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-5,12-naphthacenedione 5,12-Naphthacenedione, 8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-, (8S,10S)- | [Molecular Formula]
C21H20O9 | [MOL File]
210837-88-0.mol | [Molecular Weight]
416.38 |
Hazard Information | Back Directory | [Uses]
(8S,10S)-8-(1,2-Dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-5,12-naphthacenedione is a Dioxorubicinolone diastereomeric compound (D559050), a metabolite of Epicrubicin (E588650). Dioxorubicinolone is used in the dichroism studies on antiracycline antitumor compounds. |
|
Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Website: |
www.bocsci.com |
|